Delphinus Medical Technologies, Inc. — Form D/A

Delphinus Medical Technologies, Inc. of NOVI, MI, a company, filed a Form D amendment with the SEC on 2024-11-26. The offering totals $20.4M, of which $20.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (40)

Showing 25 of 40 people.

NameRoleLocation
Michael EmeryExecutive OfficerNOVI, MI
Michael GrossDirectorAnn Arbor, MI
Hugo BraunDirectorNOVI, MI
John NeisDirectorNOVI, MI
Michael FultonDirectorNOVI, MI
Ronald HoDirectorNOVI, MI
Rachel BremDirectorNOVI, MI
Scott WhiteDirectorChampaign, IL
Scott WhiteExecutive OfficerChampaign, IL
Mark ForchetteDirectorNOVI, MI
Mark ForchetteExecutive OfficerNOVI, MI
Elise BermanExecutive OfficerNOVI, MI
Paul McCreadieDirectorANN ARBOR, MI
Heather RoneExecutive OfficerNOVI, MI
Olivier RoyExecutive OfficerNOVI, MI
Neb DuricExecutive OfficerNOVI, MI
Shawn O'BrienExecutive OfficerNOVI, MI
John J NeisDirectorSarasota, FL
Paul J McCreadieDirectorMenlo Park, CA
Michael J FultonDirectorSt. Louis Park, MN
Debra SaundersExecutive OfficerNovi, MI
Francis DobschaExecutive OfficerNovi, MI
Michael J GrossDirectorPlymouth, MI
Hugo J BraunDirectorPlymouth, MI
Chris J SandersExecutive OfficerPlymouth, MI

Other filings by this issuer (8)

FiledFormOfferingSold
2025-04-03D/A$27.6M$27.6M
2024-04-05D$15.0M$5.3M
2023-06-30D$8.0M$5.0M
2022-09-13D$30.4M$30.4M
2017-04-20D$25.0M$8.2M
2015-09-11D$45.0M$39.5M
2010-10-12D/A$9.6M$7.2M
2010-05-21D$8.0M$6.0M

More